Company Filing History:
Years Active: 2017-2024
Title: Masahiko Higashiyama: Innovator in Pancreatic and Lung Cancer Evaluation
Introduction
Masahiko Higashiyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical technology, particularly in the evaluation of pancreatic and lung cancer. With a total of 2 patents, his work focuses on innovative methods for assessing cancer states through amino acid concentration data.
Latest Patents
Higashiyama's latest patents include a method for evaluating pancreatic cancer and a lung cancer evaluating apparatus. The pancreatic cancer evaluation method involves obtaining amino acid concentration data from blood samples and using this data to assess the state of pancreatic cancer in the subject. The method incorporates a formula that utilizes concentration values of various amino acids, including Asn, His, Thr, and others, to evaluate the cancer state effectively. Additionally, his lung cancer evaluation method measures amino acid concentration data to determine the lung cancer state based on specific amino acids present in the blood.
Career Highlights
Masahiko Higashiyama is associated with Ajinomoto Co., Ltd., a company known for its advancements in food and biotechnology. His work at Ajinomoto has allowed him to focus on developing innovative solutions for cancer evaluation, contributing to the medical field's understanding of these diseases.
Collaborations
Higashiyama has collaborated with notable colleagues, including Nobukazu Ono and Naoyuki Okamoto. These collaborations have further enhanced his research and development efforts in cancer evaluation technologies.
Conclusion
Masahiko Higashiyama's contributions to cancer evaluation through innovative methods highlight his role as a key inventor in the medical technology field. His work continues to pave the way for advancements in cancer diagnosis and treatment.